Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Hotel Mandarine Regency Tbk. (HOME) vs Organon Pharma Indonesia Tbk. (SCPI)

Hotel Mandarine Regency Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Hotel Mandarine Regency Tbk. dan Organon Pharma Indonesia Tbk.: Hotel Mandarine Regency Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 1,11 T), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Hotel Mandarine Regency Tbk. jauh lebih besar — sekitar 10,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

HOMESCPI
Kapitalisasi Pasar
1,11 T104,4 M

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

HOME
Lihat detail
SCPI
Lihat detail

Tentang Hotel Mandarine Regency Tbk.

PT Hotel Mandarine Regency Tbk (the Company) formerly known as PT Batam Jaya Hotel, was established through Notarial Deed No. 109 dated 28 October 1986 of Syawa Sutan Diatas, SH., a Notary in Pekanbaru. Based on the Notarial Deed No. 15 dated 4 November 1997 of Maria Hilaria Salim, SH., a Notary in Batam, the Company has changed its name from PT Hotal Batam Jaya to PT Hotal Mandarine Regency.

Selengkapnya di halaman HOME

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI